CN114213311A - Substituted benzaldehyde oxime ester compound and preparation method and application thereof - Google Patents

Substituted benzaldehyde oxime ester compound and preparation method and application thereof Download PDF

Info

Publication number
CN114213311A
CN114213311A CN202111616922.1A CN202111616922A CN114213311A CN 114213311 A CN114213311 A CN 114213311A CN 202111616922 A CN202111616922 A CN 202111616922A CN 114213311 A CN114213311 A CN 114213311A
Authority
CN
China
Prior art keywords
formula
compound
substituted
benzaldoxime
oxime ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111616922.1A
Other languages
Chinese (zh)
Other versions
CN114213311B (en
Inventor
李恭昊
刘旭锋
乔丽
刘幸海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN202111616922.1A priority Critical patent/CN114213311B/en
Publication of CN114213311A publication Critical patent/CN114213311A/en
Application granted granted Critical
Publication of CN114213311B publication Critical patent/CN114213311B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A01N43/38Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Indole Compounds (AREA)

Abstract

The invention discloses a substituted benzaldehyde oxime ester compound and a preparation method and application thereof, wherein the structural formula of the substituted benzaldehyde oxime ester compound is shown as the formula (I):

Description

Substituted benzaldehyde oxime ester compound and preparation method and application thereof
Technical Field
The invention belongs to the field of chemical synthesis and drug application, and particularly relates to a substituted benzaldehyde oxime ester compound and a preparation method and application thereof.
Background
With the progress and development of society, novel heterocyclic compounds have become the key point of pesticide creation and research, and the heterocyclic compounds are favored by people due to the characteristics of greenness, high efficiency, low toxicity, broad spectrum, various structures, easy modification and the like, and particularly, nitrogen-containing heterocyclic compounds with novel structures have become the hot spots of pesticide research and development. The development of compounds with novel structures by taking active natural products as lead compounds has prompted the high-efficiency broad-spectrum biological activity and has become one of the most active fields in recent years.
Because the indole structure has the characteristics of low toxicity to human bodies and good biological activity, the indole structure is widely applied to the fields of pesticides, medicines, foods, dyes and the like, thereby becoming a hot spot of green medicine research. Since Leonian et al first discovered that indole-3-acetic acid has excellent fungicidal activity in 1937, many new varieties of indole heterocycle-containing insecticides, fungicides and plant growth regulators, such as indole esters as fungicides and indole acetic acid (IBA) and indole esters (Figarin) as plant growth regulators, have been developed abroad. The invention designs and synthesizes the novel indole derivative of the substituted benzaldehyde oxime ester compound by taking Serlyticin-A as a lead structure and taking natural products of indoleacetic acid, indole propionic acid or indole butyric acid as raw materials for structural derivation.
Disclosure of Invention
The invention aims to provide a substituted benzaldehyde oxime ester compound and a preparation method and application thereof.
The substituted benzaldehyde oxime ester compound is characterized in that the structural formula is shown as the formula (I):
Figure BDA0003436646810000021
in the formula (I), n is an integer of 1-3, the number of substituents R on a benzene ring is 1-3, and R is selected from C1-C4 alkyl, halogen, nitro, C1-C4 alkoxy or halogen substituted C1-C4 alkyl.
The substituted benzaldehyde oxime ester compound is characterized in that a substituent R on a benzene ring is 4-methoxy, 2-bromo, 4-methyl, 4-fluoro, 2-nitro, 3-nitro, 2-methoxy, 4-bromo, 3-chloro, 4-trifluoromethyl, 4-chloro, 3,4, 5-trimethoxy, 3, 4-dimethoxy, 2, 4-dichloro or 2,3, 4-trimethoxy.
The preparation method of the substituted benzaldehyde oxime ester compound is characterized by comprising the following steps:
1) adding substituted benzaldehyde shown as a formula (1) into a reactor, adding an alcohol solvent, stirring and dissolving, and then dropwise and slowly adding an aqueous solution of hydroxylamine hydrochloride to react to generate a compound 2 shown as a formula (2);
2) using methyl chloride as a solvent, DMAP as a catalyst and DCC as an activating reagent, and reacting the compound of the formula (2) obtained in the step 1) with a compound raw material of the formula (3) (namely 3-indoleacetic acid, 3-indolepropionic acid or 3-indolebutyric acid) to generate a substituted benzaldehyde oxime ester compound shown as the formula (I); the reaction process is as follows:
Figure BDA0003436646810000022
the substituent R on the benzene ring in the formula (1) and the formula (2) is the same as that in the formula (I);
in the formula (3), n is an integer of 1-3.
The preparation method of the substituted benzaldehyde oxime ester compound is characterized in that when the compound 2 is synthesized in the step 1), hydroxylamine hydrochloride is dissolved in water and then slowly dripped into a reaction liquid, so that the yield is further improved. Cis-trans isomerism may occur when compound 2 is synthesized, but the oxime has poor stability in the Z configuration and will be converted to the E configuration when encountering acid in an alcohol solution. Therefore, the compound 2 exists in the E configuration.
The preparation method of the substituted benzaldehyde oxime ester compound is characterized in that in the step 1), the feeding molar ratio of substituted benzaldehyde to hydroxylamine hydrochloride to sodium carbonate is 1: 1-1.2: 1.2 to 1.6.
The preparation method of the substituted benzaldehyde oxime ester compound is characterized in that in the step 1), the reaction is carried out for 1-3 hours at room temperature by stirring, and the reaction process is tracked by TLC.
The preparation method of the substituted benzaldehyde oxime ester compound is characterized in that in the step 2), the reaction is carried out for 1-3 hours at room temperature by stirring, and the reaction process is tracked by TLC; the molar ratio of the compound of formula (2) to the compound of formula (3) to DCC to DMAP is 1: 0.8-1.2: 0.8-1.2: 0.4-0.6, preferably 1:1:1: 0.5.
The substituted benzaldehyde oxime ester compound is applied as a bactericide and is characterized in that the substituted benzaldehyde oxime ester compound is used for preparing the bactericide for inhibiting rice blast, phytophthora capsici leonian, cucumber fusarium wilt, apple ring spot, cucumber gray mold, sclerotinia sclerotiorum, rice sheath blight, wheat scab, tomato early blight or peanut brown spot.
The invention provides a preparation method of substituted benzaldehyde oxime ester compounds, which is simple in preparation method and convenient to operate, the structure of the substituted benzaldehyde oxime ester compounds is confirmed by nuclear magnetic hydrogen spectrum, 45 target products are tested for bactericidal activity in the embodiment of the invention, and the result shows that: all the substituted benzaldehyde oxime ester compounds have certain bacteriostatic activity, and the inhibition rate of the D2 compound on sclerotinia sclerotiorum and botrytis cinerea reaches over 75 percent under the concentration of 50 ug/mL; the inhibition rate of the D14 compound on sclerotinia sclerotiorum and botrytis cinerea reaches more than 60% under the concentration of 50 ug/mL; the inhibition rate of the D22 compound on rice blast, phytophthora capsici and sclerotinia sclerotiorum of rape all reaches more than 70 percent under the concentration of 50 ug/mL; the inhibition rate of the D36 compound on sclerotinia sclerotiorum and botrytis cinerea reaches more than 67 percent under the concentration of 50 ug/mL.
Detailed Description
The present invention is further illustrated by the following examples, which should not be construed as limiting the scope of the invention.
EXAMPLE 1 preparation of Compound 2
A100 mL reaction flask was charged with 1mmol of intermediate 1 (substituted benzaldehyde) and anhydrous ethanol (about 30mL) was used as a solvent, and the mixture was stirred at room temperature to dissolve the intermediate. Dissolving 1.2mmol of hydroxylamine hydrochloride and 1.5mmol of anhydrous sodium carbonate in a small beaker by using a proper amount of water, then slowly dropwise adding the solution into the reaction solution, stirring at room temperature for 1-2h, tracking the reaction progress by TLC (VEA/VPE ═ 1/4, v/v), extracting for 2-3 times by using 10mL of water and 50mL of ethyl acetate after the reaction is finished, collecting an organic phase, finally adding column chromatography silica gel, removing the solvent by rotary evaporation, and finally purifying by column chromatography to obtain an intermediate 2 (the different substituted benzaldehyde oxime). The structure of the intermediate is confirmed by nuclear magnetic resonance hydrogen spectrum, and the intermediate 2 (the differently substituted benzaldoxime) is a known compound.
Example 2 preparation of a compound of formula I (n ═ 3)
See example 1 for the procedure for the preparation of intermediate 2.
Adding dichloromethane (20mL) as a solvent, 4-dimethylaminopyridine (DMAP, 0.5mmol) as a catalyst, N, N' -dicyclohexylcarbodiimide (DCC,1mmol) as an activating reagent, adding an intermediate 2 (substituted benzaldehyde oxime, 1mmol) and a raw material (3-indolebutyric acid, 1mmol), stirring at room temperature for 2 hours, tracking and reacting by TLC (VEA/VPE (1/2, v/v)), cooling and standing after the reaction is finished, performing suction filtration, collecting filtrate, finally adding column chromatography silica gel, removing the solvent by rotary evaporation, and purifying by column chromatography to obtain a pure product of the target compound I.
Example 3 preparation of compound of formula I (n ═ 2)
See example 1 for the procedure for the preparation of intermediate 2.
Adding dichloromethane (20mL) as a solvent, 4-dimethylaminopyridine (DMAP, 0.5mmol) as a catalyst, N, N' -dicyclohexylcarbodiimide (DCC,1mmol) as an activating reagent, adding an intermediate 2 (substituted benzaldehyde oxime, 1mmol) and a raw material (3-indole propionic acid, 1mmol), stirring at room temperature for 2h, tracking and reacting by TLC (VEA/VPE (1/2, v/v)), cooling and standing after the reaction is finished, performing suction filtration, collecting filtrate, finally adding column chromatography silica gel, removing the solvent by rotary evaporation, and purifying by column chromatography to obtain a pure product of the target compound I.
Example 4 preparation of compound of formula I (n ═ 1)
See example 1 for the procedure for the preparation of intermediate 2.
Adding dichloromethane (20mL) as a solvent, 4-dimethylaminopyridine (DMAP, 0.5mmol) as a catalyst, N, N' -dicyclohexylcarbodiimide (DCC,1mmol) as an activating reagent, adding an intermediate 2 (substituted benzaldehyde oxime, 1mmol) and a raw material (3-indoleacetic acid, 1mmol), stirring at room temperature for 2 hours, tracking and reacting by TLC (VEA/VPE (1/2, v/v)), cooling and standing after the reaction is finished, performing suction filtration, collecting filtrate, finally adding column chromatography silica gel, removing the solvent by rotary evaporation, and purifying by column chromatography to obtain a pure product of the target compound I.
The reaction sequence involved in examples 2-4 is as follows:
Figure BDA0003436646810000051
Figure BDA0003436646810000061
the substituent R on the benzene ring in the formula (1) and the formula (2) is the same as that in the formula (I); in the formula (3), n is an integer of 1-3. The benzene ring substituent R in the intermediate 1 (substituted benzaldehyde), the intermediate 2 (substituted benzaldehyde oxime) and the target compound I are listed in Table 1, and the appearance and reaction yield of the corresponding target compound are also listed in Table 1. The hydrogen spectra data for each target compound are listed in table 2.
TABLE 1 physicochemical data of substituted benzaldoxime esters
Figure BDA0003436646810000062
Figure BDA0003436646810000071
TABLE 2 data of hydrogen spectra of substituted benzaldoxime compounds
Figure BDA0003436646810000072
Figure BDA0003436646810000081
Figure BDA0003436646810000091
Figure BDA0003436646810000101
Figure BDA0003436646810000111
Figure BDA0003436646810000121
Figure BDA0003436646810000131
Figure BDA0003436646810000141
Example 5 bactericidal Activity test
Test method
(1) Test subjects: pyricularia oryzae (Pyricularia oryzae), Phytophthora capsici (Phytophthora capsici), Fusarium oxysporum (Fusarium oxysporum), Phytophthora piricola (Physalospora piricola), Botrytis cinerea (Botrytis cinerea), Sclerotinia sclerotiorum (Sclerotinia sclerotiorum), Rhizoctonia solani (Riziotinia solani, Gibberella cerealis (Gibberella zeae), Phytophthora solani (Alternaria solani), and Phytophthora arachidis (Cercospora arachidicola).
(2) And (3) test treatment: the various compounds obtained need to be dissolved in DMSO to obtain EC mother liquor with mass fraction of 1% for standby. Using zone of inhibition method, each compound was evaluated for bactericidal activity in the test target chamber at a concentration of 50ppm, and a control group of clear water (QCK) and a control of indoleacetic acid (FP) with an effective content of 50ppm were additionally provided.
(3) The test method comprises the following steps: firstly, a pipette is used to suck 100 microliter of EC mother liquor, and the EC mother liquor is diluted in Tween water to prepare liquid medicine with the concentration of 500 ppm. Then a liquid transfer gun is used for sucking 1ml of liquid medicine and putting the liquid medicine into a sterilized culture dish, and then 9ml of PDA culture medium is put into the culture dish, and the liquid medicine is shaken up and cooled. And then, beating the round bacterial cake by using a puncher, picking the round bacterial cake to the center of a culture dish by using an inoculating needle, finally placing the culture dish in an incubator at 27 ℃ for culture, and measuring the diameter of a bacterial colony after 48-72 hours. The pure growth amount of the bacterial colony is the difference value of the average diameter of the bacterial colony and the diameter of the bacterial cake, and the calculation method of the inhibition rate (%) refers to the following formula.
Figure BDA0003436646810000151
The pure growth amount of the control bacterial colony in the bacteriostasis rate calculation formula refers to the result detected under the control of solvent and clear water (QCK).
The results of the activity test are shown in table 3:
TABLE 3 fungicidal activity of substituted benzaldoximes
Figure BDA0003436646810000161
Figure BDA0003436646810000171
The bactericidal activity results of the substituted benzaldoxime ester compounds (45) show that (table 3), at the concentration of 50 mu g/mL, 45 samples have certain inhibitory activity to 10 targets, and the inhibition rate of the D2 compound to sclerotinia sclerotiorum and botrytis cinerea reaches over 75% at the concentration of 50 ug/mL; the inhibition rate of the D14 compound on sclerotinia sclerotiorum and botrytis cinerea reaches more than 60% under the concentration of 50 ug/mL; the inhibition rate of the D22 compound on rice blast, phytophthora capsici and sclerotinia sclerotiorum of rape all reaches more than 70 percent under the concentration of 50 ug/mL; the inhibition rate of the D36 compound on sclerotinia sclerotiorum and botrytis cinerea reaches more than 67% under the concentration of 50 ug/mL.
The statements in this specification merely set forth a list of implementations of the inventive concept and the scope of the present invention should not be construed as limited to the particular forms set forth in the examples.

Claims (8)

1. A substituted benzaldehyde oxime ester compound is characterized in that the structural formula is shown as the formula (I):
Figure FDA0003436646800000011
in the formula (I), n is an integer of 1-3, the number of substituents R on a benzene ring is 1-3, and R is selected from C1-C4 alkyl, halogen, nitro, C1-C4 alkoxy or halogen substituted C1-C4 alkyl.
2. The substituted benzaldoxime compound of claim 1, wherein the substituent R on the benzene ring is 4-methoxy, 2-bromo, 4-methyl, 4-fluoro, 2-nitro, 3-nitro, 2-methoxy, 4-bromo, 3-chloro, 4-trifluoromethyl, 4-chloro, 3,4, 5-trimethoxy, 3, 4-dimethoxy, 2, 4-dichloro or 2,3, 4-trimethoxy.
3. A method for preparing the substituted benzaldoxime compound of claim 1, comprising the steps of:
1) adding substituted benzaldehyde shown in a formula (1) into a reactor, adding an alcohol solvent, stirring and dissolving, and then dropwise and slowly adding an aqueous solution containing sodium carbonate and hydroxylamine hydrochloride to react to generate a compound shown in a formula (2);
2) using methyl chloride as a solvent, DMAP as a catalyst and DCC as an activating reagent, and reacting the compound of the formula (2) obtained in the step 1) with the compound of the formula (3) to generate a substituted benzaldehyde oxime ester compound shown in the formula (I); the reaction process is as follows:
Figure FDA0003436646800000012
Figure FDA0003436646800000021
the substituent R on the benzene ring in the formula (1) and the formula (2) is the same as that in the formula (I);
in the formula (3), n is an integer of 1-3.
4. The method for preparing substituted benzaldoxime esters according to claim 3, wherein in step 1), the molar ratio of substituted benzaldoxime to hydroxylamine hydrochloride and sodium carbonate is 1: 1-1.2: 1.2 to 1.6.
5. The method for preparing substituted benzaldoxime esters as claimed in claim 3, wherein the reaction in step 1) is stirred at room temperature for 1-3 h, and TLC tracks the reaction progress.
6. The method for preparing substituted benzaldoxime esters compound as claimed in claim 3, wherein the reaction in step 2) is stirred at room temperature for 1-3 h, TLC tracks the reaction process; the molar ratio of the compound of formula (2) to the compound of formula (3) to DCC to DMAP is 1: 0.8-1.2: 0.8-1.2: 0.4-0.6, preferably 1:1:1: 0.5.
7. The use of the substituted benzaldoxime ester compound of claim 1 as a fungicide.
8. The use as claimed in claim 7, characterized in that the substituted benzaldoxime compounds are used for preparing fungicides for inhibiting Pyricularia oryzae, Phytophthora capsici, Fusarium oxysporum, Verticillium pomonella, Botrytis cinerea, Sclerotinia sclerotiorum, Rhizoctonia solani, Rhizoctonia cerealis, Phytophthora solani or Physalospora arachidicola.
CN202111616922.1A 2021-12-27 2021-12-27 Substituted benzaldehyde oxime ester compound and preparation method and application thereof Active CN114213311B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111616922.1A CN114213311B (en) 2021-12-27 2021-12-27 Substituted benzaldehyde oxime ester compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111616922.1A CN114213311B (en) 2021-12-27 2021-12-27 Substituted benzaldehyde oxime ester compound and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN114213311A true CN114213311A (en) 2022-03-22
CN114213311B CN114213311B (en) 2023-10-31

Family

ID=80706244

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111616922.1A Active CN114213311B (en) 2021-12-27 2021-12-27 Substituted benzaldehyde oxime ester compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114213311B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115093343A (en) * 2022-06-17 2022-09-23 西北农林科技大学 Pinane oxime ester compound, preparation method and application

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037770A1 (en) * 2002-10-23 2004-05-06 Nippon Soda Co.,Ltd. Hydrazine derivative, intermediate for production, and bactericide and insecticide for agricultural or horticultural use
CN102718731A (en) * 2012-07-03 2012-10-10 天津商业大学 4 /5-methyl-1, 2, 3-thiadiazole formic acid derivative and preparation method thereof
CN104744297A (en) * 2015-04-15 2015-07-01 广西大学 Anti-hepatitis B virus (HBV) activity phenylpropanoid benzaldehyde oxime ester type compounds
CN106665607A (en) * 2016-12-26 2017-05-17 蔡志浩 Compound plant fungicide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037770A1 (en) * 2002-10-23 2004-05-06 Nippon Soda Co.,Ltd. Hydrazine derivative, intermediate for production, and bactericide and insecticide for agricultural or horticultural use
CN102718731A (en) * 2012-07-03 2012-10-10 天津商业大学 4 /5-methyl-1, 2, 3-thiadiazole formic acid derivative and preparation method thereof
CN104744297A (en) * 2015-04-15 2015-07-01 广西大学 Anti-hepatitis B virus (HBV) activity phenylpropanoid benzaldehyde oxime ester type compounds
CN106665607A (en) * 2016-12-26 2017-05-17 蔡志浩 Compound plant fungicide

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CUMHUR KIRILMIS,等: "Synthesis and antimicrobial activity of some novel derivatives of benzofuran: Part 2. The synthesis and antimicrobial activity of some novel 1-(1-benzofuran-2-yl)-2-mesitylethanone derivatives" *
HIKTOR KOAIOZKIEWICE,等: "2-HYDROXXIPINO-2-PHBNYLACETONITRIALCBT IVE ESTERS IN PEPTIDE SYNTHBSIS" *
VIVEK AHLUWALIA,等: "Synthesis and antimicrobial activity of esters of 3-ethoxy-4-hydroxybenzaldehyde oxime" *
马军安,等: "取代甲醛肟羧酸酯的合成及生物活性研究( V) —拟除虫菊酸4-二甲( 乙) 氨基苯甲醛肟酯抗植物病毒活性" *
马军安,等: "取代苯甲醛肟羧酸酯的合成及生物活性研究(IV)——拟除虫菊酸4-二甲( 乙) 氨基苯甲醛肟酯的合成及生物活性" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115093343A (en) * 2022-06-17 2022-09-23 西北农林科技大学 Pinane oxime ester compound, preparation method and application
CN115093343B (en) * 2022-06-17 2023-06-23 西北农林科技大学 Pinonyl oxime ester compound, preparation method and application

Also Published As

Publication number Publication date
CN114213311B (en) 2023-10-31

Similar Documents

Publication Publication Date Title
KR101067805B1 (en) N-2-heteroarylethylcarboxamide derivative, and pest-controlling agent comprising the same
JP4945042B2 (en) Trifluoromethylpyrrole carboxamide and trifluoromethylpyrrolethioamide as fungicides
JP4836383B2 (en) Pyrrole carboxamides and pyrrole thioamides as fungicides
CN112062759B (en) Ethylsulfonyl-containing pyridine-1, 2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof
CN109810062B (en) Phenylimidazole derivative, synthesis method thereof and application of phenylimidazole derivative in pesticide
CA3150249A1 (en) Piperonylic acid derivative and application thereof
WO2014187298A1 (en) N-pyridine amide compound, preparation method therefor, and application thereof
CN114213311A (en) Substituted benzaldehyde oxime ester compound and preparation method and application thereof
JP4706482B2 (en) Pyridylmethyl derivative of 2,6-dichloroisonicotinic acid, method for producing the same, and agricultural and horticultural disease control agent
CN114276287B (en) N- (substituted benzyloxy) amide compound and preparation method and application thereof
CN110734403B (en) (S) -2- (1H-pyrazole-4-formamido) propyl benzoate compound and preparation method and application thereof
CN112209894B (en) 5-aryl substituted 2-aminobenzoxazole derivative, preparation method and application thereof
CN115925680B (en) Trifluoromethyl-containing pyridine compound and preparation method and application thereof
CN115197131A (en) Azo 2-amino benzyl nicotinate derivative and preparation method and application thereof
CN116239533B (en) Difluoromethyl pyrazole carboxamide compounds containing benzoate (amide), preparation method and application thereof
CN110903227B (en) Nitroguanidine compound and preparation and application thereof
CN114957124B (en) 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof
CN116162063B (en) Pyrazole formylhydroxylamine compound containing bisamide bond, and preparation method and application thereof
WO1999012907A1 (en) 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
JP4534452B2 (en) 3-methylisothiazole-5-methanol derivative, process for producing the same, and agricultural and horticultural disease control
CN114957123B (en) 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof
CN116178263B (en) Nitro-containing pyrazole carboxamide compound as well as preparation method and application thereof
CN115141142B (en) 2, 3-dimethyl-8-fluoroquinoline-4-ether compound and application thereof
CN113896722B (en) Benzamide compound containing thiadiazole group and preparation method and application thereof
CN116082324A (en) Heterocyclic 1,2, 4-oxadiazole compound, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant